Sunzen Biotech Berhad (KLSE: SUNZEN)

Sunzen Biotech Berhad Ratios and Metrics

Market cap in millions MYR. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 19, 2024	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	245	249	211	141	176	95
Market Cap Growth	68.51%	17.94%	50.06%	-20.14%	85.39%	71.43%
Enterprise Value	234	243	203	130	162	81
Last Close Price	0.32	0.35	0.30	0.20	0.25	0.18
PE Ratio	42.96	41.38	31.11	37.59	259.44	-
PS Ratio	2.34	2.62	2.15	1.45	1.95	1.16
PB Ratio	1.61	1.66	1.53	1.09	1.41	1.02
P/TBV Ratio	1.83	1.83	1.68	1.18	1.53	1.09
P/FCF Ratio	26.63	27.10	23.87	-	-	15.75
P/OCF Ratio	25.39	25.39	22.44	-	-	13.21
EV/Sales Ratio	2.46	2.56	2.07	1.33	1.79	0.98
EV/EBITDA Ratio	17.72	18.61	14.16	12.93	26.11	-
EV/EBIT Ratio	21.59	21.92	16.64	16.58	41.23	-
EV/FCF Ratio	25.38	26.43	22.95	-	-	13.37
Debt / Equity Ratio	0.05	0.05	0.06	0.04	0.04	0.17
Debt / EBITDA Ratio	0.57	0.57	0.54	0.50	0.86	-
Debt / FCF Ratio	0.83	0.83	0.88	-	-	2.56
Asset Turnover	-	-	0.63	0.65	0.67	0.65
Inventory Turnover	-	-	6.80	5.78	5.68	6.00
Quick Ratio	5.56	5.56	4.74	2.55	4.15	2.25
Current Ratio	7.11	7.11	5.60	3.53	5.22	3.56
Return on Equity (ROE)	-	-	5.98%	3.74%	1.77%	-13.54%
Return on Assets (ROA)	-	-	4.93%	3.26%	1.81%	-6.06%
Return on Capital (ROIC)	-	-	5.44%	3.67%	2.05%	-6.84%
Earnings Yield	2.33%	2.42%	3.21%	2.66%	0.39%	-13.90%
FCF Yield	3.76%	3.69%	4.19%	-24.37%	-10.63%	6.35%
Buyback Yield / Dilution	-0.56%	-7.67%	4.24%	-33.52%	-13.24%	-0.15%
Total Shareholder Return	-0.56%	-7.67%	4.24%	-33.52%	-13.24%	-0.15%

Source: S&P Capital IQ. Standard template. Financial Sources.